Last reviewed · How we verify

NCT05647694

V-NAV Usability Study: End Users Trying the Vortant Indoor Navigation Tool

Suspended NA Last updated 25 November 2024
What this trial tests

NA trial testing V-NAV indoor navigation prototype in Blindness and Low Vision in 16 participants. Suspended.

Timeline
1 January 2025
Primary endpoint
30 April 2025
30 April 2025

Quick facts

Lead sponsorVortant Technologies, LLC
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment16
Start date1 January 2025
Primary completion30 April 2025
Estimated completion30 April 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vortant Technologies, LLC

Who can join

12 and older, any sex, with Blindness and Low Vision. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will begin with an explanatory/training session where individuals with low vision will learn to use the V-NAV (Vortant NAVigation tool) indoor navigation app, and will have the opportunity to try it for a few representative tasks. The main activity includes a take-home trial, an extended unstructured period to emulate the post-purchase experience of users, during which participants will have the opportunity to use the V-NAV in their everyday lives. Data will be collected from the users to measure the relative advantage of V-NAV compared to the user's current indoor navigation method.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Blindness and Low Vision

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05647694.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing